                         SEQUENCE LISTING

<110>  Dana-Farber Cancer Institute, Inc.
       President and Fellows of Harvard College
       Kadoch, Cigall
       Garcia-Rivera, Enrique
       Maetani, Micah
       Schreiber, Stuart L
 
<120>  COMPOUNDS AND METHODS FOR TREATING SYNOVIAL SARCOMAS

<130>  167741.014301

<140>  PCT/US2016/062296
<141>  2016-11-16

<150>  62/255,767
<151>  2015-11-16

<160>  1     

<170>  PatentIn version 3.5

<210>  1
<211>  385
<212>  PRT
<213>  Homo sapiens

<400>  1

Met Met Met Met Ala Leu Ser Lys Thr Phe Gly Gln Lys Pro Val Lys 
1               5                   10                  15      


Phe Gln Leu Glu Asp Asp Gly Glu Phe Tyr Met Ile Gly Ser Glu Val 
            20                  25                  30          


Gly Asn Tyr Leu Arg Met Phe Arg Gly Ser Leu Tyr Lys Arg Tyr Pro 
        35                  40                  45              


Ser Leu Trp Arg Arg Leu Ala Thr Val Glu Glu Arg Lys Lys Ile Val 
    50                  55                  60                  


Ala Ser Ser His Gly Lys Lys Thr Lys Pro Asn Thr Lys Asp His Gly 
65                  70                  75                  80  


Tyr Thr Thr Leu Ala Thr Ser Val Thr Leu Leu Lys Ala Ser Glu Val 
                85                  90                  95      


Glu Glu Ile Leu Asp Gly Asn Asp Glu Lys Tyr Lys Ala Val Ser Ile 
            100                 105                 110         


Ser Thr Glu Pro Pro Thr Tyr Leu Arg Glu Gln Lys Ala Lys Arg Asn 
        115                 120                 125             


Ser Gln Trp Val Pro Thr Leu Pro Asn Ser Ser His His Leu Asp Ala 
    130                 135                 140                 


Val Pro Cys Ser Thr Thr Ile Asn Arg Asn Arg Met Gly Arg Asp Lys 
145                 150                 155                 160 


Lys Arg Thr Phe Pro Leu Cys Phe Asp Asp His Asp Pro Ala Val Ile 
                165                 170                 175     


His Glu Asn Ala Ser Gln Pro Glu Val Leu Val Pro Ile Arg Leu Asp 
            180                 185                 190         


Met Glu Ile Asp Gly Gln Lys Leu Arg Asp Ala Phe Thr Trp Asn Met 
        195                 200                 205             


Asn Glu Lys Leu Met Thr Pro Glu Met Phe Ser Glu Ile Leu Cys Asp 
    210                 215                 220                 


Asp Leu Asp Leu Asn Pro Leu Thr Phe Val Pro Ala Ile Ala Ser Ala 
225                 230                 235                 240 


Ile Arg Gln Gln Ile Glu Ser Tyr Pro Thr Asp Ser Ile Leu Glu Asp 
                245                 250                 255     


Gln Ser Asp Gln Arg Val Ile Ile Lys Leu Asn Ile His Val Gly Asn 
            260                 265                 270         


Ile Ser Leu Val Asp Gln Phe Glu Trp Asp Met Ser Glu Lys Glu Asn 
        275                 280                 285             


Ser Pro Glu Lys Phe Ala Leu Lys Leu Cys Ser Glu Leu Gly Leu Gly 
    290                 295                 300                 


Gly Glu Phe Val Thr Thr Ile Ala Tyr Ser Ile Arg Gly Gln Leu Ser 
305                 310                 315                 320 


Trp His Gln Lys Thr Tyr Ala Phe Ser Glu Asn Pro Leu Pro Thr Val 
                325                 330                 335     


Glu Ile Ala Ile Arg Asn Thr Gly Asp Ala Asp Gln Trp Cys Pro Leu 
            340                 345                 350         


Leu Glu Thr Leu Thr Asp Ala Glu Met Glu Lys Lys Ile Arg Asp Gln 
        355                 360                 365             


Asp Arg Asn Thr Arg Arg Met Arg Arg Leu Ala Asn Thr Ala Pro Ala 
    370                 375                 380                 


Trp 
385 


